Medical Devices Russia

Russia Anastomosis Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Russia Anastomosis Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Type, By Application, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Buy the full report

Report snapshot

Russia Anastomosis Devices Market Analysis at a glance
Market size, 2025Researched figures come with the full report
Forecast, 2034Researched figures come with the full report
Growth (CAGR), 2025–2034Researched figures come with the full report
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersMedtronic, LivaNova PLC, Johnson & Johnson, Stryker, MAQUET Holding B.V. & Co. KG and 2 more (see all)
Regulator in RussiaRoszdravnadzorSource: Roszdravnadzor. Checked 14 Nov 2026.
Active clinical trials11 in RussiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

The Russia Anastomosis Devices Market Executive Summary

An anastomotic device is a surgical tool used to join blood vessels or other tubular structures in the body; it is made out of silk, resorbable and does not require suture applications. These devices are supposed to be easy to use, have high crush resistance and the ability to stimulate tissue regeneration.

The Anastomosis Devices Market is a relatively small and specific part of the medical device market, covering the equipment used for joining blood vessels or segments of the intestines during operations. It encompasses both mechanical and electronic applications and supports cardiovascular, gastrointestinal, and urological operations. It is fueled by technological innovations like the use of robots in surgery, minimal invasive procedures, increasing cases of chronic diseases and global population growing older. Notable manufacturers and developers are Medtronic, Johnson & Johnson, Stryker, and B. Braun Melsungen. However, like any market in its development stage, there are barriers including high costs and regulations. In general, the sector continues to positively develop due to constant innovations and the growth of surgical requirements.

Russia Anastomosis Devices Market Dynamics

Market Growth Drivers

The rise in surgical anastomosis due to chronic diseases for instance, cardiovascular ailments, cancer and others has also boosted the market. Another factor adding to the increase is the tendency towards performing minimally invasive surgeries that have numerous advantages, including short periods of rehabilitation and less trauma. A growing aged populace, particularly in emerging markets such as Asia-Pacific, also increases the demand for such gadgets. Technologic innovations such as new materials and designs like stapling in the three dimensions offer better surgical results and productivity.

Opportunity

Computer aided and robotic surgery, fast track stapling and magnetically controlled anastomosis remain promising avenues to enhance surgical performance. There is potential for growth in BRIC countries and especially in Asia-Pacific which have tendency to strengthen their healthcare systems. This focus on biodegradable materials can coincides with heightened concern with patient safety and could spur market acceptance. Secondly, increasing instances of organ transplant surgeries necessitate the use of effective anastomosis devices.

Market Restraints

Higher prices of advanced devices can pose a problem as they remain expensive to acquire and implement especially in the constrained healthcare systems of developing nations. Problems like leaks and post-surgery bleeding may cause patients to refrain from using them, thus affecting patients’ well-being. High regulatory standards can slow down product releases and drive-up prices, while low reimbursement standards reduce access to these devices. Also, availability of less invasive techniques, could also lower the utilization rate for anastomosis procedures.

Competitive Landscape for Anastomosis Devices Market in Russia

Key Players

Recent Developments

August 2024, Colospan, which develops novel solutions for colorectal surgery, announced that USFDA has granted Breakthrough Device Designation to its CG-100 Intraluminal Bypass Device.

May 2024, Ethicon Launches ECHELON LINEAR™ Cutter, a First-of-its-Kind Surgical Stapler That Delivered 47% Fewer Leaks at the Staple Line to Help Reduce Surgical Risks.

May 2024, Sony Group Corporation (Sony) announced the development of a microsurgery assistance robot capable of automatic surgical instrument exchange and precision control. The prototype will be unveiled at the Sony booth during the 2024 Institute of Electrical and Electronics Engineers (IEEE) International Conference on Robotics and Automation (ICRA2024), which opens in Yokohama on May 13.

Healthcare Policies and Regulatory Landscape for Anastomosis Devices Market in Russia

Anastomosis Devices in Russia: rules, payment and research

Medical devices are registered by Roszdravnadzor, the federal health care regulator.⁠[1] Compulsory medical insurance (OMS) pays for a guaranteed package of free care, through the Federal Compulsory Medical Insurance Fund.⁠[2] ClinicalTrials.gov lists 11 studies on Anastomosis Devices that are recruiting, active or about to start in Russia.⁠[3]

[1] Roszdravnadzor. Checked 14 Nov 2026.

[2] Federal Compulsory Medical Insurance Fund. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Having favourable regulations in areas, such as North America and Europe where there is swift approvals for new and innovative devices, aids in boosting the market size. Lucrative clinical specifications demanding minimal invasiveness and recent healthcare policies in surgical operating room technology also contribute to the increase in demand for anastomosis devices. Reimbursement policies in developed countries are also favourable since they create demand while insufficient coverage in emerging markets is a concern. The global outbreak of COVID-19 has led to the postponement of elective procedures; however, as health systems adapt and move forward, there is likely to be a rise in demand for these devices due to better reimbursement situations.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Anastomosis Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Anastomosis Devices in context

Russia compared

  • Health spending per person: 1,003 US$ per person (2023). World: 1,317 US$ per person (2023). 12th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 5.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 17.8% of people (2025). World: 10.4% of people (2025). 12th highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

What segments does the Anastomosis Devices market report cover?
The report splits the market by type (Reusable Devices, Disposable Devices), application (Gastrointestinal Surgery, Cardiovascular Surgery, Others) and end user (Hospitals, Ambulatory Care Centres, Clinics).
Who are the key players in the Anastomosis Devices market?
Key players include Medtronic, LivaNova PLC, Johnson & Johnson, Stryker, MAQUET Holding B.V. & Co. KG and Dextera Surgical Inc., among 7 companies the report profiles.
What is driving the Anastomosis Devices market?
The rise in surgical anastomosis due to chronic diseases for instance, cardiovascular ailments, cancer and others has also boosted the market.
Who regulates Anastomosis Devices in Russia?
Medical devices are registered by Roszdravnadzor, the federal health care regulator. Source: Roszdravnadzor. Checked 14 Nov 2026.
How is healthcare paid for in Russia?
Compulsory medical insurance (OMS) pays for a guaranteed package of free care, through the Federal Compulsory Medical Insurance Fund. Source: Federal Compulsory Medical Insurance Fund. Checked 14 Nov 2026.
How many clinical trials on Anastomosis Devices are running in Russia?
11 studies are recruiting, active or about to start in Russia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Russia. Retrieved 9 Nov 2026.
How much research is published on Anastomosis Devices?
PubMed lists 1,598 papers on Anastomosis Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Russia

See all

Related on surgery

See the topic